Weight and Healthcare

This Substack explores the intersections of weight science, healthcare, and public health with a focus on evidence, ethics, and the impact of weight stigma on higher-weight individuals. It critiques weight-based healthcare practices, diet culture, and pharmaceutical interventions, advocating for weight-neutral healthcare approaches and challenging prevailing narratives around weight and health.

Weight Stigma in Healthcare Weight Loss Industry Critique Ethical Issues in Weight Management Health at Every Size (HAES) Weight-Neutral Healthcare Practices Impact of Diet Culture Medical Bias and Discrimination Evidence-Based Approaches to Health Public Health and Obesity Narratives Weight Loss Drugs and Interventions

The hottest Substack posts of Weight and Healthcare

And their main takeaways
439 implied HN points 20 Mar 24
  1. Eli Lilly and other pharmaceutical companies are focused on lobbying for insurance coverage of weight loss drugs, pushing for the idea of higher-weight bodies as a 'disease' worth medicating.
  2. The FDA approval for weight loss drugs like Zepbound requires different criteria based on BMI, raising concerns about the risk assessments being tied to body size.
  3. Pharmaceutical companies like Eli Lilly prioritize shareholder interests over customer concerns, raising questions about the true motivations behind their actions.
639 implied HN points 27 Jan 24
  1. Medical students are advocating for size inclusivity in healthcare, aiming for equitable treatment regardless of weight.
  2. Learning about weight-neutral care helps medical students challenge biases and provide comprehensive healthcare to patients of all body sizes.
  3. Resistance to weight-inclusive care exists in the medical field, but progress is being made towards more size-inclusive medical education and practices.
1178 implied HN points 13 May 23
  1. Jenny Craig, a popular commercial diet program, is shutting down after decades. Despite its promises of weight loss, it failed to show long-term results in studies.
  2. Commercial diet programs like Jenny Craig often rely on a cycle of success and failure, blaming clients for weight regain without acknowledging the limitations of restrictive diets.
  3. The closure of Jenny Craig is a reminder of the lack of evidence behind many weight loss programs, as clients are left without sustainable results.
1138 implied HN points 09 Jul 23
  1. Many weight loss interventions are based on flawed models and fail long-term, leading to weight regain as the body adjusts to food restriction.
  2. The focus on weight loss often overlooks the importance of ensuring that individuals receive adequate nutrition during interventions, potentially putting their health at risk.
  3. Moving towards a weight-neutral paradigm in healthcare can prioritize supporting the health of individuals of all sizes instead of promoting unhealthy weight loss methods and stigma.
738 implied HN points 27 Dec 23
  1. Using percentages without proper context can be misleading, it's crucial to provide a full picture for accurate interpretation.
  2. Understanding the difference between relative and absolute risk in statistics can prevent manipulation and provide a clearer view of the data.
  3. Different methods for handling dropouts in trials, like LOCF and BOCF, can impact outcomes significantly and need careful consideration in research.
Get a weekly roundup of the best Substack posts, by hacker news affinity:
219 implied HN points 15 May 24
  1. Leslie Jordan Garcia is a body liberation coach with a background in community health and certifications in eating disorder recovery.
  2. She learned about weight neutral and body affirming care through personal experience transitioning to plus size and followed HAES principles.
  3. In her work, Leslie focuses on movement, pleasure, and embracing diverse identities, emphasizing that health is about more than just physical appearance.
1078 implied HN points 19 Aug 23
  1. Telling Type 2 Diabetes patients to just eat less sweets and carbs is oversimplified and unhelpful advice, as the condition is complex and requires individualized approaches.
  2. Understanding the complexity of Type 2 Diabetes management is crucial for healthcare practitioners, as simple directives can be harmful and ineffective.
  3. Non-restrictive, weight-neutral strategies exist for managing blood sugar levels in Type 2 Diabetes, highlighting the importance of personalized care and professional guidance.
1078 implied HN points 09 Aug 23
  1. Novo Nordisk released a press release touting study results that were not peer-reviewed or published, raising ethical concerns.
  2. The study population in the trial for the weight loss drug Wegovy was limited to specific criteria, excluding certain groups for evaluation of benefits and risks.
  3. The publicity stunt around the drug's benefits showcases the pharmaceutical company's marketing tactics that may manipulate perceptions and stock prices.
1058 implied HN points 02 Aug 23
  1. Non-compliance labeling in healthcare can have negative implications on patients, especially when it comes to weight loss recommendations.
  2. There is a strong emphasis on the importance of reframing health as supporting behaviors rather than just focusing on weight loss as a measure of compliance.
  3. Many weight loss interventions lack long-term efficacy and can result in weight cycling, leading to patient dissatisfaction and potential harm.
978 implied HN points 17 Jun 23
  1. The AMA's new BMI policy acknowledges the historical harm, racist exclusion, and limitations of using BMI, suggesting it be used alongside other measures.
  2. The AMA's recognition of the limitations of BMI doesn't fully address the core issue of pathologizing bodies based on size, perpetuating weight stigma and inequalities in healthcare.
  3. The AMA's connection to the weight loss industry raises concerns about their motives behind the new policy, impacting healthcare decisions and patient care.
758 implied HN points 22 Nov 23
  1. During the holiday season, there is often an increase in diet culture behaviors like food policing and body shaming.
  2. Strategies like ignoring/responding silently, setting boundaries, and engaging in conversations can help navigate inappropriate comments about food and body during gatherings.
  3. It's important to prioritize enjoying meals in peace and remember that others' opinions about our food choices are not our concern.
798 implied HN points 08 Nov 23
  1. Higher-weight patients may face challenges in accessing appropriate healthcare services, such as imaging scans like CT scans.
  2. Patients should not have to navigate through healthcare system barriers on their own and should receive accurate information about medical procedures upfront.
  3. Advocacy and education are important for challenging medical weight stigma and ensuring equitable healthcare access for all patients.
918 implied HN points 05 Jul 23
  1. The column discusses weight stigma and hypocrisy in healthcare, pointing out discrimination based on body size.
  2. It highlights the importance of respecting boundaries and being cautious with compliments related to body size manipulation.
  3. The response from the Ethicist regarding concerns about weight loss drugs brings to light inconsistencies and potential ethical issues.
798 implied HN points 01 Nov 23
  1. Healthcare practitioners should provide informed consent without patients having to ask for it, and dismissing concerns about side effects violates medical ethics.
  2. Wegovy, a weight loss medication, has serious side effects including contraindications for certain medical conditions, fetal harm, and common side effects like nausea and abdominal pain.
  3. The FDA-approved documentation and research show significant adverse events associated with Wegovy, challenging the idea that the drug is safe and raising important questions about long-term use.
718 implied HN points 18 Nov 23
  1. Require five-year follow-up with mandatory publication to improve accuracy and information in weight loss studies
  2. Mandate essential information in bold print at the beginning of weight loss studies to ensure transparency and accessibility
  3. Implement a weight-neutral comparator group in weight loss studies to distinguish impacts of behavior changes from weight loss, reducing health risks
858 implied HN points 31 May 23
  1. The National Eating Disorders Association replaced their helpline staff with an AI-driven chatbot after the staff unionized, which is concerning.
  2. The AI chatbot provided harmful information and promoted weight loss to individuals seeking support for eating disorders, raising serious ethical questions.
  3. The behavior of the NEDA leadership in response to concerns about the chatbot's harmful advice was dismissive and misleading, leading to a lack of trust in the organization's ethics.
858 implied HN points 05 Aug 23
  1. The concept of body-size-as-disease is constructed by the diet industry and lacks scientific grounding.
  2. Engaging in intentional weight loss contradicts being a part of the Health at Every Size community.
  3. Research suggests that weight-neutral interventions can offer similar cardiometabolic benefits with fewer risks compared to weight loss drugs.
619 implied HN points 09 Dec 23
  1. Ask what treatment would be given to a thin person with the same issue to navigate weight stigma in healthcare.
  2. Assert your right to informed refusal to treatment when faced with weight-related recommendations or pressure.
  3. Redirect the focus of the conversation back to your healthcare needs and away from weight discussions using a phrase like 'I'd like to focus on...' to ensure patient-centered care.
838 implied HN points 30 Aug 23
  1. Some are considering renaming 'obesity' to remove stigma and redefine the illness concept.
  2. The term 'obesity' being considered a disease is fueled by the weight loss industry and may not be the best approach.
  3. Efforts to rename 'obesity' might simply be masking the failed concept with a new label.
639 implied HN points 29 Nov 23
  1. The weight loss industry is a for-profit industry that profits by labeling higher-weight individuals as diseased, creating harmful messaging and interventions.
  2. The industry has successfully infiltrated healthcare systems, promoting the idea that being in a higher-weight body is a lifelong, chronic disease.
  3. Industry tactics include promoting weight loss drugs as lifelong solutions, perpetuating weight stigma under the guise of helping higher-weight individuals, and making hundreds of billions of dollars through exploitative practices.
818 implied HN points 06 Sep 23
  1. A healthcare system should provide equal care to individuals of all sizes, moving towards truly weight-inclusive healthcare.
  2. Research and practices in medicine should include fat patients to improve outcomes for higher-weight individuals.
  3. Weight-inclusive healthcare could reduce weight cycling and improve the health of fat individuals, challenging the ineffective weight-centric care system that has been in place for decades.
758 implied HN points 11 Oct 23
  1. Obesity is not an addiction like alcohol or gambling; it is simply defined by a BMI of 30 or higher.
  2. Alcohol use disorder and gambling disorders have specific diagnostic criteria and shared behaviors, while obesity is not behavior-based.
  3. The concept of food addiction is controversial, and pathologizing higher weight bodies can be rooted in racism and anti-Blackness and perpetuated by the weight loss industry.
758 implied HN points 27 May 23
  1. The study on Wegovy's long-term effects raised concerns about the definition of 'long-term' in the context of a 2-year study.
  2. The conflicts of interest among the study authors, who receive funding and support from Novo Nordisk, the drug manufacturer, raise questions about the study's credibility.
  3. The study revealed high rates of adverse events among participants taking Semaglutide, emphasizing the risks associated with such weight loss medications.
738 implied HN points 23 Aug 23
  1. Healthcare practitioners often blame and shame fat patients for failed intentional weight loss, creating barriers to compassionate care.
  2. The weight loss industry acknowledges the failure of behavioral weight loss interventions, but their push for risky methods like drugs and surgeries is dangerous.
  3. Instead of blaming fat people for weight loss failure, healthcare should focus on respecting and affirming their humanity while supporting their health.
698 implied HN points 18 Oct 23
  1. The workshop highlighted weight stigma issues in healthcare, emphasizing the harmful effects of reinforcing stereotypes based on body weight.
  2. The promotion of weight loss as a solution to health issues was criticized, raising questions about the effectiveness and ethics of focusing on weight reduction.
  3. The financial ties between speakers at the workshop and pharmaceutical companies were exposed, leading to concerns about potential conflicts of interest in the healthcare industry.
718 implied HN points 12 Jul 23
  1. Pathologizing fatness contributes to weight stigma and can dehumanize fat individuals, perpetuating discrimination and exclusion.
  2. Traditional weight stigma reduction methods that shift blame or rely on empathy fail to address the root cause of pathologizing fatness and are ineffective in dismantling weight stigma.
  3. Efforts to eradicate weight stigma should focus on depathologizing fatness, creating interventions that challenge stigma's underlying foundations and embracing collaboration with stigmatized communities.
758 implied HN points 29 Apr 23
  1. Weight loss research often relies on the energy deficit approach despite a high failure rate, leading to misrepresentation of evidence.
  2. Claims suggesting 5-10% weight loss offers significant health benefits lack substantial evidence and may not be accurate.
  3. Weight loss studies tend to overlook adverse effects of dieting, neglect other clinical outcomes beyond weight loss, and maintain an overly optimistic tone despite high failure rates observed in long-term interventions.
698 implied HN points 22 Jul 23
  1. The outcomes of hip surgery for higher-weight individuals were found to be better in a new study, which challenges common beliefs about weight and healthcare.
  2. It's important to consider various factors impacting surgical outcomes beyond just weight, such as individual characteristics, bias, and pre-surgery weight loss attempts.
  3. Even if there are complications, all individuals, regardless of weight, should have access to healthcare and surgeries to reduce pain and improve quality of life.
718 implied HN points 06 May 23
  1. Weight stigma in healthcare can be a common issue for higher-weight patients.
  2. Healthcare providers may focus excessively on weight loss even when it may not be relevant to the patient's health concerns.
  3. Patients have the right to refuse weight-focused care and can navigate discussions with their healthcare providers by explaining their reasoning or bypassing weight discussions.
678 implied HN points 20 Sep 23
  1. The study analyzed the impact of warning labels on sugary drinks but the media misrepresented the findings, leading to weight stigma.
  2. Existing research shows that interventions focusing on positive, weight-neutral health messages are most beneficial for people of all sizes.
  3. Media coverage often perpetuates weight stigma and misinformation, impacting public perception and potentially harming individuals.
678 implied HN points 14 Jun 23
  1. Beachbody's rebrand to 'BODi' does not truly represent a commitment to weight-neutral fitness, despite efforts to suggest otherwise.
  2. Their promotional materials and programs still heavily focus on weight loss and diet culture, with no substantial evidence provided for long-term weight loss efficacy.
  3. The rebranding claims to honor all shapes and sizes but seems to continue promoting weight loss and thin bodies as the ideal, lacking true fat-affirming or weight-neutral approaches.
678 implied HN points 03 Jun 23
  1. Medical students should re-evaluate weight-stigma projects to make a real impact.
  2. Addressing systemic fat oppression in healthcare requires tangible actions like reviewing curriculum and infrastructure.
  3. Med students possess a unique position to challenge anti-fat practices and bring about meaningful change.
678 implied HN points 10 May 23
  1. The concept of 'obesity' based on BMI can be problematic and does not account for individual health variations.
  2. Classifications of obesity, especially in healthcare, can lead to biased treatment recommendations favoring weight loss over evidence-based, weight-neutral care.
  3. The arbitrary nature of BMI 'classes' for obesity can result in significant differences in treatment recommendations with just small changes in weight, perpetuating weight stigma and inequality in healthcare.
579 implied HN points 04 Nov 23
  1. Wegovy is a weight-loss drug that has not been around for a long time, as it is a repurposed version of another drug called semaglutide, with evolving risks and warnings.
  2. Wegovy and Ozempic differ in dosage and treatment purpose, with Wegovy aiming to maximize weight loss side effects at a high dose that exceeds the maximum dose of Ozempic.
  3. Informed consent conversations with healthcare practitioners are essential, especially when considering drugs like Wegovy with significant side effects and dosage differences.
918 implied HN points 01 Mar 23
  1. Obesity being labeled as a chronic disease like asthma and type 2 diabetes is misleading and harmful.
  2. The weight loss industry benefits from portraying obesity as a disease, pushing for lifelong treatments like expensive drugs.
  3. The enmeshment of the weight loss industry in healthcare can lead to misinformation and harm, as well-meaning healthcare practitioners get caught up in it.